A small retrospective study (without a control group) investigated the possible effects of SGLT2 inhibitors in 18 T2D patients with OSA regarding weight reduction and changes in AHI [109]
GLP-1RAs promote weight loss by suppressing appetite
Gigliotti, MS, RDN, CDCES, CSOWM
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes and, more recently, some have been approved for weight management
Compared to earlier analogs, GHRP-2 provides intense somatotropic stimulation with more moderate activation of central orexigenic (appetite-stimulating) pathways, allowing researchers to study growth hormone surges in isolation from extreme systemic metabolic flux
Both contain the same NAD+ molecule